Back to explore

The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double‐blind, controlled trial

1 Assessments

1 Serious · 0 Some · 0 No · 0 N/A

ReviewerDateQ1.1Does the study have an associated retraction?Q1.2Does the study have an associated expression of concern or other relevant post-publication notice?Q1.3Do other studies by the research team highlight causes for concern?Q2.2Are there concerns relating to the timing or absence of study registration?OverallActions
RV019

Evidence Synthesis Methdos Lead

8 Mar 2026
No
No
Yes
Yes
Serious concernsView

Publication Details

Journal
Phytotherapy Research
Publisher
Wiley
Published
2 Mar 2023
Pages
pp. 2957–2964
ISSN / eISSN
0951-418X / 1099-1573
The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double‐blind, controlled trial | RIPE Knowledge Graph